| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phospholipid binding | TNFAIP8L3 DOK7 SPTBN1 MYO1B PICALM PXK CADPS CIBAR1 SBF2 ARHGAP44 RACGAP1 AKT1 PRKCI | 2.18e-05 | 548 | 118 | 13 | GO:0005543 |
| GeneOntologyMolecularFunction | histone deacetylase binding | 2.71e-05 | 147 | 118 | 7 | GO:0042826 | |
| GeneOntologyMolecularFunction | glucosamine-6-phosphate deaminase activity | 3.46e-05 | 2 | 118 | 2 | GO:0004342 | |
| GeneOntologyMolecularFunction | deaminase activity | 4.69e-05 | 34 | 118 | 4 | GO:0019239 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | 1.10e-04 | 316 | 118 | 9 | GO:0035091 | |
| GeneOntologyMolecularFunction | calmodulin binding | 4.38e-04 | 230 | 118 | 7 | GO:0005516 | |
| GeneOntologyMolecularFunction | protein dimerization activity | ANO2 SUPT3H MEF2B FMR1 MYOM3 SRF XPA IDE CHKA MEF2A PTGS2 MEF2C MEF2D FZD9 CLCN1 CDADC1 AKT1 | 7.16e-04 | 1205 | 118 | 17 | GO:0046983 |
| GeneOntologyMolecularFunction | lipid binding | TNFAIP8L3 TEX2 DOK7 SPTBN1 MYO1B NR3C1 PICALM PXK CADPS CIBAR1 SBF2 ARHGAP44 RACGAP1 AKT1 PRKCI | 7.20e-04 | 988 | 118 | 15 | GO:0008289 |
| GeneOntologyBiologicalProcess | regulation of protein localization to membrane | VPS26B DOK7 SPTBN1 IQSEC2 PICALM FZD9 ARHGAP44 AKT1 PRKCI EFCAB7 | 1.01e-06 | 237 | 117 | 10 | GO:1905475 |
| GeneOntologyBiologicalProcess | regulation of protein localization to cell periphery | 6.00e-06 | 171 | 117 | 8 | GO:1904375 | |
| GeneOntologyBiologicalProcess | muscle cell fate determination | 3.19e-05 | 2 | 117 | 2 | GO:0007521 | |
| GeneOntologyBiologicalProcess | glucosamine catabolic process | 3.19e-05 | 2 | 117 | 2 | GO:0006043 | |
| GeneOntologyBiologicalProcess | UV-damage excision repair | 6.19e-05 | 14 | 117 | 3 | GO:0070914 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance | 7.68e-05 | 40 | 117 | 4 | GO:0097242 | |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | KNTC1 FMR1 NEBL MYOM3 SRF MEF2A MEF2C MDN1 ASPM RACGAP1 MRTO4 | 8.32e-05 | 475 | 117 | 11 | GO:0140694 |
| GeneOntologyBiologicalProcess | negative regulation of synaptic transmission | 9.23e-05 | 80 | 117 | 5 | GO:0050805 | |
| GeneOntologyBiologicalProcess | embryonic heart tube morphogenesis | 9.23e-05 | 80 | 117 | 5 | GO:0003143 | |
| GeneOntologyBiologicalProcess | ureteric peristalsis | 9.54e-05 | 3 | 117 | 2 | GO:0072105 | |
| GeneOntologyBiologicalProcess | ureter smooth muscle contraction | 9.54e-05 | 3 | 117 | 2 | GO:0014849 | |
| GeneOntologyBiologicalProcess | N-acetylglucosamine catabolic process | 9.54e-05 | 3 | 117 | 2 | GO:0006046 | |
| GeneOntologyBiologicalProcess | synaptic transmission, glutamatergic | 1.07e-04 | 132 | 117 | 6 | GO:0035249 | |
| GeneOntologyBiologicalProcess | negative regulation of plasma membrane bounded cell projection assembly | 1.22e-04 | 45 | 117 | 4 | GO:0120033 | |
| GeneOntologyBiologicalProcess | myofibril assembly | 1.30e-04 | 86 | 117 | 5 | GO:0030239 | |
| GeneOntologyBiologicalProcess | muscle cell fate commitment | 1.36e-04 | 18 | 117 | 3 | GO:0042693 | |
| GeneOntologyBiologicalProcess | striated muscle cell development | 1.53e-04 | 89 | 117 | 5 | GO:0055002 | |
| GeneOntologyBiologicalProcess | mammary placode formation | 1.90e-04 | 4 | 117 | 2 | GO:0060596 | |
| GeneOntologyBiologicalProcess | cardiac myofibril assembly | 2.20e-04 | 21 | 117 | 3 | GO:0055003 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | GABRB2 FMR1 IQSEC2 SRF GRIK1 VPS54 NR3C1 PTGS2 MEF2C PXK UBE3A CADPS ARHGAP44 PRKAR2A AKT1 | 2.51e-04 | 931 | 117 | 15 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | GABRB2 FMR1 IQSEC2 SRF GRIK1 VPS54 NR3C1 PTGS2 MEF2C PXK UBE3A CADPS ARHGAP44 PRKAR2A AKT1 | 2.51e-04 | 931 | 117 | 15 | GO:0007268 |
| GeneOntologyBiologicalProcess | regulation of synaptic plasticity | 2.70e-04 | 293 | 117 | 8 | GO:0048167 | |
| GeneOntologyBiologicalProcess | cardiocyte differentiation | 2.70e-04 | 221 | 117 | 7 | GO:0035051 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | GABRB2 FMR1 IQSEC2 SRF GRIK1 VPS54 NR3C1 PTGS2 MEF2C PXK UBE3A CADPS ARHGAP44 PRKAR2A AKT1 | 2.75e-04 | 939 | 117 | 15 | GO:0099537 |
| GeneOntologyBiologicalProcess | muscle system process | TBX3 SRF VPS54 NR3C1 MEF2A PTGS2 MEF2C RYR2 CLCN1 SNTB1 TBX2 | 2.84e-04 | 547 | 117 | 11 | GO:0003012 |
| GeneOntologyBiologicalProcess | embryonic heart tube development | 3.03e-04 | 103 | 117 | 5 | GO:0035050 | |
| GeneOntologyBiologicalProcess | regulation of filopodium assembly | 3.08e-04 | 57 | 117 | 4 | GO:0051489 | |
| GeneOntologyBiologicalProcess | atrioventricular canal morphogenesis | 3.15e-04 | 5 | 117 | 2 | GO:1905222 | |
| GeneOntologyBiologicalProcess | regulation of cellular respiration | 3.29e-04 | 58 | 117 | 4 | GO:0043457 | |
| GeneOntologyBiologicalProcess | muscle structure development | TBX3 MEF2B NEBL MYOM3 SRF VPS54 NR3C1 MEF2A MEF2C MEF2D RYR2 AKT1 IL4 TBX2 | 3.61e-04 | 858 | 117 | 14 | GO:0061061 |
| GeneOntologyBiologicalProcess | striated muscle cell differentiation | 3.93e-04 | 391 | 117 | 9 | GO:0051146 | |
| GeneOntologyBiologicalProcess | synaptic signaling | GABRB2 FMR1 IQSEC2 SRF GRIK1 VPS54 NR3C1 PTGS2 MEF2C PXK UBE3A CADPS ARHGAP44 PRKAR2A AKT1 | 4.14e-04 | 976 | 117 | 15 | GO:0099536 |
| GeneOntologyBiologicalProcess | cardiac jelly development | 4.71e-04 | 6 | 117 | 2 | GO:1905072 | |
| GeneOntologyBiologicalProcess | negative regulation of filopodium assembly | 4.71e-04 | 6 | 117 | 2 | GO:0051490 | |
| GeneOntologyBiologicalProcess | glucosamine metabolic process | 4.71e-04 | 6 | 117 | 2 | GO:0006041 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell differentiation | 5.22e-04 | 177 | 117 | 6 | GO:0055007 | |
| GeneOntologyBiologicalProcess | cardiac muscle tissue development | 5.59e-04 | 327 | 117 | 8 | GO:0048738 | |
| GeneOntologyCellularComponent | glutamatergic synapse | GABRB2 ANO2 FMR1 VPS26B SPTB SPTBN1 IQSEC2 GRIK1 NR3C1 FZD9 UBE3A CADPS ARHGAP44 PRKAR2A AKT1 PRKCI | 1.60e-05 | 817 | 119 | 16 | GO:0098978 |
| GeneOntologyCellularComponent | postsynapse | GABRB2 RPL37A FMR1 VPS26B DOK7 SPTB SPTBN1 IQSEC2 RPS9 RPS10 GRIK1 NR3C1 PICALM MEF2C FZD9 UBE3A ARHGAP44 AKT1 | 1.79e-05 | 1018 | 119 | 18 | GO:0098794 |
| GeneOntologyCellularComponent | nucleotide-excision repair complex | 4.93e-05 | 13 | 119 | 3 | GO:0000109 | |
| HumanPheno | Obesity | CUL4B TBX3 MAK FMR1 SPTBN1 IQSEC2 NR3C1 XRCC4 MEF2A PNPLA6 UBE3A SDC3 AKT1 SNRNP200 | 1.68e-05 | 425 | 47 | 14 | HP:0001513 |
| Domain | MADS_BOX_1 | 5.52e-11 | 6 | 118 | 5 | PS00350 | |
| Domain | MADS | 5.52e-11 | 6 | 118 | 5 | SM00432 | |
| Domain | SRF-TF | 5.52e-11 | 6 | 118 | 5 | PF00319 | |
| Domain | MADS_BOX_2 | 5.52e-11 | 6 | 118 | 5 | PS50066 | |
| Domain | TF_MADSbox | 1.92e-10 | 7 | 118 | 5 | IPR002100 | |
| Domain | MADS_MEF2-like | 1.51e-09 | 4 | 118 | 4 | IPR033896 | |
| Domain | HJURP_C | 9.79e-07 | 4 | 118 | 3 | IPR022102 | |
| Domain | HJURP_C | 9.79e-07 | 4 | 118 | 3 | PF12347 | |
| Domain | TBX | 3.96e-05 | 2 | 118 | 2 | IPR022582 | |
| Domain | Glucosamine6P_isomerase_CS | 3.96e-05 | 2 | 118 | 2 | IPR018321 | |
| Domain | TBX | 3.96e-05 | 2 | 118 | 2 | PF12598 | |
| Domain | Glucosamine6P_isomerase | 3.96e-05 | 2 | 118 | 2 | IPR004547 | |
| Domain | GLC_GALNAC_ISOMERASE | 3.96e-05 | 2 | 118 | 2 | PS01161 | |
| Domain | PH | 6.84e-05 | 278 | 118 | 9 | SM00233 | |
| Domain | PH_domain | 7.23e-05 | 280 | 118 | 9 | IPR001849 | |
| Domain | SBF2 | 1.18e-04 | 3 | 118 | 2 | PF12335 | |
| Domain | SBF1/SBF2 | 1.18e-04 | 3 | 118 | 2 | IPR022096 | |
| Domain | Spectrin_bsu | 2.36e-04 | 4 | 118 | 2 | IPR016343 | |
| Domain | Glc/Gal-6P_isomerase | 2.36e-04 | 4 | 118 | 2 | IPR006148 | |
| Domain | Glucosamine_iso | 2.36e-04 | 4 | 118 | 2 | PF01182 | |
| Domain | PH_DOMAIN | 3.97e-04 | 279 | 118 | 8 | PS50003 | |
| Domain | Myosin_TH1 | 8.14e-04 | 7 | 118 | 2 | PF06017 | |
| Domain | Myosin_TH1 | 8.14e-04 | 7 | 118 | 2 | IPR010926 | |
| Domain | TH1 | 8.14e-04 | 7 | 118 | 2 | PS51757 | |
| Domain | IQ | 1.06e-03 | 71 | 118 | 4 | PF00612 | |
| Domain | CNMP_BINDING_1 | 1.07e-03 | 32 | 118 | 3 | PS00888 | |
| Domain | CNMP_BINDING_2 | 1.07e-03 | 32 | 118 | 3 | PS00889 | |
| Domain | cNMP_binding | 1.28e-03 | 34 | 118 | 3 | PF00027 | |
| Domain | cNMP-bd_dom | 1.39e-03 | 35 | 118 | 3 | IPR000595 | |
| Domain | CNMP_BINDING_3 | 1.39e-03 | 35 | 118 | 3 | PS50042 | |
| Domain | PH_dom-like | 1.54e-03 | 426 | 118 | 9 | IPR011993 | |
| Domain | cNMP-bd-like | 1.77e-03 | 38 | 118 | 3 | IPR018490 | |
| Domain | IQ_motif_EF-hand-BS | 2.55e-03 | 90 | 118 | 4 | IPR000048 | |
| Domain | IQ | 2.87e-03 | 93 | 118 | 4 | PS50096 | |
| Domain | PH | 3.35e-03 | 229 | 118 | 6 | PF00169 | |
| Domain | - | 3.40e-03 | 391 | 118 | 8 | 2.30.29.30 | |
| Domain | Myotubularin-like_Pase_dom | 3.43e-03 | 14 | 118 | 2 | IPR010569 | |
| Domain | uDENN | 3.43e-03 | 14 | 118 | 2 | SM00800 | |
| Domain | PPASE_MYOTUBULARIN | 3.43e-03 | 14 | 118 | 2 | PS51339 | |
| Domain | Myotubularin_fam | 3.43e-03 | 14 | 118 | 2 | IPR030564 | |
| Domain | Myotub-related | 3.43e-03 | 14 | 118 | 2 | PF06602 | |
| Domain | - | 3.46e-03 | 48 | 118 | 3 | 2.60.120.10 | |
| Domain | uDENN | 3.94e-03 | 15 | 118 | 2 | PF03456 | |
| Domain | RmlC-like_jellyroll | 4.11e-03 | 51 | 118 | 3 | IPR014710 | |
| Domain | GRAM | 4.48e-03 | 16 | 118 | 2 | SM00568 | |
| Domain | DENN | 4.48e-03 | 16 | 118 | 2 | SM00799 | |
| Domain | DENN | 4.48e-03 | 16 | 118 | 2 | PF02141 | |
| Domain | dDENN | 4.48e-03 | 16 | 118 | 2 | PF03455 | |
| Domain | UDENN | 4.48e-03 | 16 | 118 | 2 | PS50946 | |
| Domain | DDENN | 4.48e-03 | 16 | 118 | 2 | PS50947 | |
| Domain | dDENN | 4.48e-03 | 16 | 118 | 2 | SM00801 | |
| Domain | dDENN_dom | 4.48e-03 | 16 | 118 | 2 | IPR005112 | |
| Domain | uDENN_dom | 4.48e-03 | 16 | 118 | 2 | IPR005113 | |
| Domain | DENN | 4.48e-03 | 16 | 118 | 2 | PS50211 | |
| Domain | DENN_dom | 4.48e-03 | 16 | 118 | 2 | IPR001194 | |
| Domain | TF_T-box | 5.06e-03 | 17 | 118 | 2 | IPR001699 | |
| Domain | TBOX | 5.06e-03 | 17 | 118 | 2 | SM00425 | |
| Domain | TF_T-box_CS | 5.06e-03 | 17 | 118 | 2 | IPR018186 | |
| Domain | - | 5.06e-03 | 17 | 118 | 2 | 2.60.40.820 | |
| Domain | TBOX_3 | 5.06e-03 | 17 | 118 | 2 | PS50252 | |
| Domain | T-box | 5.06e-03 | 17 | 118 | 2 | PF00907 | |
| Domain | TBOX_1 | 5.06e-03 | 17 | 118 | 2 | PS01283 | |
| Domain | TBOX_2 | 5.06e-03 | 17 | 118 | 2 | PS01264 | |
| Pathway | WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION | 6.41e-08 | 18 | 87 | 5 | M39393 | |
| Pathway | WP_CELL_DIFFERENTIATION_INDEX | 1.36e-05 | 50 | 87 | 5 | M39528 | |
| Pathway | REACTOME_MYOGENESIS | 2.86e-05 | 29 | 87 | 4 | M853 | |
| Pathway | WP_CELL_DIFFERENTIATION_EXPANDED_INDEX | 3.07e-05 | 59 | 87 | 5 | M39723 | |
| Pubmed | 1.30e-10 | 4 | 119 | 4 | 8575763 | ||
| Pubmed | 1.30e-10 | 4 | 119 | 4 | 10207130 | ||
| Pubmed | 1.30e-10 | 4 | 119 | 4 | 21531906 | ||
| Pubmed | 1.30e-10 | 4 | 119 | 4 | 25416778 | ||
| Pubmed | 1.30e-10 | 4 | 119 | 4 | 22764880 | ||
| Pubmed | Expression of mef2 genes in the mouse central nervous system suggests a role in neuronal maturation. | 1.30e-10 | 4 | 119 | 4 | 7643214 | |
| Pubmed | CUL4B RPL37A FMR1 RPS9 RPS10 ABCF2 MYO1B SUCLG1 IGF2BP2 PNPLA6 SUB1 SBF2 SMARCA1 PYGL MRTO4 SNRNP200 | 2.70e-10 | 601 | 119 | 16 | 33658012 | |
| Pubmed | The MEF2B homologue differentially expressed in mouse embryonal carcinoma cells. | 6.50e-10 | 5 | 119 | 4 | 7646512 | |
| Pubmed | Galpha13 regulates MEF2-dependent gene transcription in endothelial cells: role in angiogenesis. | 6.50e-10 | 5 | 119 | 4 | 19093215 | |
| Pubmed | Regulatory role of MEF2D in serum induction of the c-jun promoter. | 6.50e-10 | 5 | 119 | 4 | 7760790 | |
| Pubmed | 6.50e-10 | 5 | 119 | 4 | 8993831 | ||
| Pubmed | Calcineurin initiates skeletal muscle differentiation by activating MEF2 and MyoD. | 6.50e-10 | 5 | 119 | 4 | 12694204 | |
| Pubmed | 6.50e-10 | 5 | 119 | 4 | 10458488 | ||
| Pubmed | 6.50e-10 | 5 | 119 | 4 | 23511190 | ||
| Pubmed | Influence of natriuretic peptide receptor-1 on survival and cardiac hypertrophy during development. | 1.26e-09 | 15 | 119 | 5 | 19782130 | |
| Pubmed | The expression of MEF2 genes is implicated in CNS neuronal differentiation. | 1.94e-09 | 6 | 119 | 4 | 9013788 | |
| Pubmed | MEF2B Instructs Germinal Center Development and Acts as an Oncogene in B Cell Lymphomagenesis. | 9.02e-09 | 8 | 119 | 4 | 30205047 | |
| Pubmed | 2.69e-08 | 10 | 119 | 4 | 30276662 | ||
| Pubmed | In vivo analysis of MEF2 transcription factors in synapse regulation and neuronal survival. | 3.91e-08 | 3 | 119 | 3 | 22496871 | |
| Pubmed | 3.91e-08 | 3 | 119 | 3 | 15728583 | ||
| Pubmed | 3.91e-08 | 3 | 119 | 3 | 15834131 | ||
| Pubmed | An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133. | 3.91e-08 | 3 | 119 | 3 | 18093911 | |
| Pubmed | 3.91e-08 | 3 | 119 | 3 | 27989458 | ||
| Pubmed | 3.91e-08 | 3 | 119 | 3 | 26286136 | ||
| Pubmed | 3.91e-08 | 3 | 119 | 3 | 33315889 | ||
| Pubmed | Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. | 4.22e-08 | 11 | 119 | 4 | 9162005 | |
| Pubmed | 6.31e-08 | 12 | 119 | 4 | 28641113 | ||
| Pubmed | 8.06e-08 | 32 | 119 | 5 | 20111592 | ||
| Pubmed | 1.27e-07 | 14 | 119 | 4 | 12130539 | ||
| Pubmed | TEF-1 and MEF2 transcription factors interact to regulate muscle-specific promoters. | 1.56e-07 | 4 | 119 | 3 | 12061776 | |
| Pubmed | 1.56e-07 | 4 | 119 | 3 | 31420455 | ||
| Pubmed | 1.56e-07 | 4 | 119 | 3 | 8817457 | ||
| Pubmed | Requirement of MEF2A, C, and D for skeletal muscle regeneration. | 1.56e-07 | 4 | 119 | 3 | 24591619 | |
| Pubmed | MEF2C transcription factor controls chondrocyte hypertrophy and bone development. | 3.00e-07 | 17 | 119 | 4 | 17336904 | |
| Pubmed | Control of the SOST bone enhancer by PTH using MEF2 transcription factors. | 3.89e-07 | 5 | 119 | 3 | 17696759 | |
| Pubmed | 3.89e-07 | 5 | 119 | 3 | 15084602 | ||
| Pubmed | 3.89e-07 | 5 | 119 | 3 | 20833138 | ||
| Pubmed | MEF2 transcription factors are key regulators of sprouting angiogenesis. | 3.89e-07 | 5 | 119 | 3 | 27898394 | |
| Pubmed | Interaction of myocyte enhancer factor 2 (MEF2) with a mitogen-activated protein kinase, ERK5/BMK1. | 3.89e-07 | 5 | 119 | 3 | 9753748 | |
| Pubmed | Regulation of the MEF2 family of transcription factors by p38. | 3.89e-07 | 5 | 119 | 3 | 9858528 | |
| Pubmed | 3.89e-07 | 5 | 119 | 3 | 8900141 | ||
| Pubmed | 3.89e-07 | 5 | 119 | 3 | 16504037 | ||
| Pubmed | CDK17 RPL37A TEX2 SPTBN1 RPS10 POR NR3C1 NCBP3 MDN1 PNPLA6 SBF1 ASPM PRKAR2A PRKCI MRTO4 SNRNP200 GPAT4 MRPL1 SNTB1 | 7.28e-07 | 1487 | 119 | 19 | 33957083 | |
| Pubmed | Akt binds prohibitin 2 and relieves its repression of MyoD and muscle differentiation. | 7.75e-07 | 6 | 119 | 3 | 15173318 | |
| Pubmed | 7.75e-07 | 6 | 119 | 3 | 20399744 | ||
| Pubmed | 7.75e-07 | 6 | 119 | 3 | 10737771 | ||
| Pubmed | 1.35e-06 | 7 | 119 | 3 | 12861002 | ||
| Pubmed | Mef2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis. | 1.35e-06 | 7 | 119 | 3 | 8026334 | |
| Pubmed | CUL4B TBX3 SUPT3H FMR1 XPC SUCLG1 SLC35G1 IGF2BP2 PNPLA6 SAT1 CADPS CIBAR1 ASPM SMARCA1 MAP2K7 TBX2 | 1.38e-06 | 1116 | 119 | 16 | 31753913 | |
| Pubmed | 2.16e-06 | 8 | 119 | 3 | 16043483 | ||
| Pubmed | Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2. | 2.16e-06 | 8 | 119 | 3 | 17158926 | |
| Pubmed | Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibers. | 2.16e-06 | 8 | 119 | 3 | 17786239 | |
| Pubmed | 3.23e-06 | 9 | 119 | 3 | 9738004 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SPTBN1 RPS9 RPS10 ABCF2 MYO1B XPC IGF2BP2 MDN1 PNPLA6 SBF1 UBE3A ASPM SMARCA1 RACGAP1 PYGL MRTO4 SNRNP200 | 3.72e-06 | 1353 | 119 | 17 | 29467282 |
| Pubmed | 4.35e-06 | 32 | 119 | 4 | 21768366 | ||
| Pubmed | Mef2d is essential for the maturation and integrity of retinal photoreceptor and bipolar cells. | 4.35e-06 | 32 | 119 | 4 | 25757744 | |
| Pubmed | 6.32e-06 | 11 | 119 | 3 | 20139090 | ||
| Pubmed | RPL37A FMR1 RPS9 RPS10 ABCF2 MYO1B XPC IGF2BP2 MDN1 PNPLA6 RACGAP1 MRTO4 SNRNP200 | 7.04e-06 | 847 | 119 | 13 | 35850772 | |
| Pubmed | 7.23e-06 | 383 | 119 | 9 | 19453261 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | KNTC1 RPL37A FMR1 SPTBN1 RPS9 RPS10 POR ABCF2 MYO1B IDE MDN1 SMARCA1 RACGAP1 PRKAR2A PRKCI MRTO4 SNRNP200 | 7.36e-06 | 1425 | 119 | 17 | 30948266 |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | FMR1 SPTBN1 RPS9 RPS10 MYO1B NCBP3 IGF2BP2 MDN1 SMARCA1 MRTO4 SNRNP200 | 7.80e-06 | 605 | 119 | 11 | 28977666 |
| Pubmed | Skeletal muscle specification by myogenin and Mef2D via the SWI/SNF ATPase Brg1. | 8.40e-06 | 12 | 119 | 3 | 16424906 | |
| Pubmed | 1.09e-05 | 13 | 119 | 3 | 21447557 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 12616532 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 18645534 | ||
| Pubmed | Regulation of Akt(ser473) phosphorylation by choline kinase in breast carcinoma cells. | 1.16e-05 | 2 | 119 | 2 | 20042122 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 20056640 | ||
| Pubmed | IL-4 regulates COX-2 and PGE2 production in human non-small cell lung cancer. | 1.16e-05 | 2 | 119 | 2 | 16574063 | |
| Pubmed | Loss of myocyte enhancer factor 2 expression in osteoclasts leads to opposing skeletal phenotypes. | 1.16e-05 | 2 | 119 | 2 | 32512162 | |
| Pubmed | Increased rates of cerebral glucose metabolism in a mouse model of fragile X mental retardation. | 1.16e-05 | 2 | 119 | 2 | 12427968 | |
| Pubmed | Molecular Pathway to Protection From Age-Dependent Photoreceptor Degeneration in Mef2 Deficiency. | 1.16e-05 | 2 | 119 | 2 | 28738418 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 23388722 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 30223900 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 17611778 | ||
| Pubmed | The T-box transcription factors TBX2 and TBX3 in mammary gland development and breast cancer. | 1.16e-05 | 2 | 119 | 2 | 23624936 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 11285198 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 19925030 | ||
| Pubmed | T-cell glucocorticoid receptor is required to suppress COX-2-mediated lethal immune activation. | 1.16e-05 | 2 | 119 | 2 | 12949501 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 17653764 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 28604419 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 25394776 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 23382706 | ||
| Pubmed | Mouse models for xeroderma pigmentosum group A and group C show divergent cancer phenotypes. | 1.16e-05 | 2 | 119 | 2 | 18316597 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 22941172 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 29890290 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 36436184 | ||
| Pubmed | Glucocorticoid receptor changes its cellular location with breast cancer development. | 1.16e-05 | 2 | 119 | 2 | 17952860 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 30699340 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 8008830 | ||
| Pubmed | Myocyte enhancer factors 2A and 2C induce dilated cardiomyopathy in transgenic mice. | 1.16e-05 | 2 | 119 | 2 | 16469744 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 25336633 | ||
| Pubmed | Two mammalian glucosamine-6-phosphate deaminases: a structural and genetic study. | 1.16e-05 | 2 | 119 | 2 | 12965206 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 9430690 | ||
| Pubmed | Clinical profile and mutation analysis of xeroderma pigmentosum in Indian patients. | 1.16e-05 | 2 | 119 | 2 | 25566891 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 26831662 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 21633703 | ||
| Pubmed | Regulation of myocyte enhancer factor-2 transcription factors by neurotoxins. | 1.16e-05 | 2 | 119 | 2 | 21741404 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 17431507 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 20434996 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 34718573 | ||
| Interaction | MEF2B interactions | 3.57e-07 | 11 | 118 | 4 | int:MEF2B | |
| Interaction | BORCS8-MEF2B interactions | 1.45e-06 | 15 | 118 | 4 | int:BORCS8-MEF2B | |
| Interaction | FBXW7 interactions | CUL4B RPL37A FMR1 SPTBN1 RPS9 RPS10 ABCF2 MYO1B XPA NR3C1 XRCC4 SUCLG1 IGF2BP2 PNPLA6 TIMP4 SUB1 SBF2 SMARCA1 PYGL AKT1 MRTO4 SNRNP200 | 1.94e-06 | 1215 | 118 | 22 | int:FBXW7 |
| Interaction | MEF2C interactions | 1.59e-05 | 54 | 118 | 5 | int:MEF2C | |
| Interaction | ECT2 interactions | FMR1 RBMXL3 MYO1A SPTB SPTBN1 RPS9 RPS10 POR MYO1B SUCLG1 PICALM IGF2BP2 ASPM RACGAP1 MRTO4 SNRNP200 MRPL1 | 1.60e-05 | 887 | 118 | 17 | int:ECT2 |
| Interaction | KIF23 interactions | FMR1 RBMXL3 MYO1A SPTBN1 RPS9 RPS10 POR MYO1B AK9 IGF2BP2 TNRC18 CLCN1 ASPM RACGAP1 PRKAR2A PRKCI MRTO4 SNRNP200 | 3.06e-05 | 1031 | 118 | 18 | int:KIF23 |
| GeneFamily | Myocyte enhancer factor 2 proteins|MADS box family | 1.15e-12 | 5 | 76 | 5 | 1086 | |
| GeneFamily | Myocyte enhancer factor 2 proteins|MADS box family | 2.88e-10 | 4 | 76 | 4 | 649 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.53e-05 | 206 | 76 | 7 | 682 | |
| GeneFamily | EF-hand domain containing|Spectrins | 3.61e-04 | 7 | 76 | 2 | 1113 | |
| GeneFamily | WD repeat domain containing|Xeroderma pigmentosum complementation groups|Nucleotide excision repair | 4.80e-04 | 8 | 76 | 2 | 1125 | |
| GeneFamily | Myosins, class I | 4.80e-04 | 8 | 76 | 2 | 1097 | |
| GeneFamily | Myotubularins|Phosphoinositide phosphatases | 1.77e-03 | 15 | 76 | 2 | 903 | |
| GeneFamily | T-boxes | 2.55e-03 | 18 | 76 | 2 | 766 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 4.91e-03 | 25 | 76 | 2 | 504 | |
| GeneFamily | Pyrin domain containing|Pyrin and HIN domain family | 4.91e-03 | 25 | 76 | 2 | 994 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | KNTC1 SUPT3H RPL37A TEX2 RPS9 ABCF2 MDN1 ASPM SMARCA1 PYGL MRTO4 SNRNP200 SNTB1 | 4.39e-06 | 612 | 119 | 13 | M4772 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | CUL4B SUPT3H FMR1 SPTBN1 NR3C1 XRCC4 MEF2A MEF2C SHQ1 NCBP3 SIDT2 MDN1 UBE3A PRKCI OTULINL SNRNP200 UBFD1 | 3.52e-05 | 1215 | 119 | 17 | M41122 |
| Coexpression | GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_4H_DN | 3.58e-05 | 199 | 119 | 7 | M8707 | |
| Coexpression | GSE17721_LPS_VS_PAM3CSK4_16H_BMDC_DN | 3.69e-05 | 200 | 119 | 7 | M3929 | |
| Coexpression | GSE16385_ROSIGLITAZONE_VS_UNTREATED_IFNG_TNF_STIM_MACROPHAGE_UP | 3.69e-05 | 200 | 119 | 7 | M7894 | |
| CoexpressionAtlas | dev gonad_e11.5_M_SupCellPrec_Sry_top-relative-expression-ranked_500 | CUL4B SOX5 CHKA RYR2 GXYLT2 SIDT2 IGF2BP2 TNRC18 SLC26A7 CADPS SMARCA1 | 2.73e-05 | 432 | 117 | 11 | gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500 | 3.24e-05 | 162 | 117 | 7 | gudmap_developingGonad_e16.5_epididymis_500_k2 | |
| CoexpressionAtlas | dev gonad_e11.5_M_SupCellPrec_Sry_k-means-cluster#3_top-relative-expression-ranked_500 | 6.19e-05 | 123 | 117 | 6 | gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_k3_500 | |
| ToppCell | mild-immature_Neutrophil|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.93e-06 | 83 | 119 | 5 | f7225bc24ad6df3a41375cc4614af824e0db3559 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.45e-06 | 178 | 119 | 6 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D122|Adult / Lineage, Cell type, age group and donor | 9.89e-06 | 183 | 119 | 6 | fc31a43a637423cb3bb9aa184a3a889a0b9aaea6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-05 | 185 | 119 | 6 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-05 | 185 | 119 | 6 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 | |
| ToppCell | mild-immature_Neutrophil|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.12e-05 | 109 | 119 | 5 | 2f03d6ee8b13424cc6a5bc60ac3461b44dff9d79 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | 1.12e-05 | 187 | 119 | 6 | 62759efb660179402fb574ce5701c89a2e17bcfe | |
| ToppCell | COVID-19-Heart-CM_4|Heart / Disease (COVID-19 only), tissue and cell type | 1.22e-05 | 190 | 119 | 6 | 3729648a17093b438398b82e32bbccc3af7b8c5d | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.22e-05 | 190 | 119 | 6 | a21653bfb7bafbc273f94fa7c13bfb48cf8fd562 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.26e-05 | 191 | 119 | 6 | 1626b23a57429f835fddc052e3c57f63a4e5b8bb | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.26e-05 | 191 | 119 | 6 | 716dfa7fccbd62b5f574792e68a26dc6c45511dc | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.30e-05 | 192 | 119 | 6 | 935a4a36881a9fa4daa02cba96af07f6686ed8d6 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.30e-05 | 192 | 119 | 6 | 4c9d748f209cc1e13d28c8c7f5180ab8522e0fbf | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.30e-05 | 192 | 119 | 6 | c4efc170852abbcf0c53c2b0f8a0cc9fe7f116c8 | |
| ToppCell | CF-Lymphoid|CF / Disease state, Lineage and Cell class | 1.34e-05 | 193 | 119 | 6 | 11de07d13a7da223990b56fa89ba7fc1c3dd0122 | |
| ToppCell | control-Epithelial-Basal|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.39e-05 | 114 | 119 | 5 | 276e32c2e04c4c060078cd5277ac5a9ae02033f8 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-05 | 195 | 119 | 6 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.46e-05 | 196 | 119 | 6 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | tumor_Lung-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 1.50e-05 | 197 | 119 | 6 | 44f37a98f07c3e46a7e8fd3b64c2b2b44d5bbe40 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.55e-05 | 198 | 119 | 6 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.55e-05 | 198 | 119 | 6 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.55e-05 | 198 | 119 | 6 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.55e-05 | 198 | 119 | 6 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.55e-05 | 198 | 119 | 6 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.59e-05 | 199 | 119 | 6 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | Caecum-B_cell-B_cell_memory|Caecum / Region, Cell class and subclass | 1.64e-05 | 200 | 119 | 6 | 5a954d366762c6838cc6ec3ae05ed908e5f120b5 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.64e-05 | 200 | 119 | 6 | 0c648941447c738caf62f2d71e296d6cca492c8b | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.64e-05 | 200 | 119 | 6 | 8158f4eaeff945a6788c8e732b7a1b0d78052a06 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.64e-05 | 200 | 119 | 6 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Caecum-(2)_B_cell-(22)_B_cell_memory|Caecum / shred on region, Cell_type, and subtype | 1.64e-05 | 200 | 119 | 6 | 8e71f3518cde586fe0b8dfa3f6ee57e85e10ad4e | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.64e-05 | 200 | 119 | 6 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Pericyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.64e-05 | 200 | 119 | 6 | 600d56257b1b0cda8ed2fd0db92c6551711f7d6d | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.64e-05 | 200 | 119 | 6 | 94f1fa61aa82eb9f411b2b1cb759476939ab5db7 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.60e-05 | 139 | 119 | 5 | fa0eedebf53317928022c3bed391ce99a2114f98 | |
| ToppCell | Lymphoid-Lymphoid-NK_cells|Lymphoid / shred on cell class and cell subclass (v4) | 4.86e-05 | 148 | 119 | 5 | d51a4b654a88d58dcdf29c2bc362c0cc1c40723a | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 7.04e-05 | 160 | 119 | 5 | 19105debef96ea0c267d6a1d332303ec668ae47e | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.25e-05 | 161 | 119 | 5 | d02f8c01b26158a06e109eb603b0fe76372ec983 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.14e-05 | 165 | 119 | 5 | 1d844d19ff9b49dd0f61f0b24799e172076771ef | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.14e-05 | 165 | 119 | 5 | 9a6abd0e6b11860231ce5e845c87b8d66f3ef697 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.14e-05 | 165 | 119 | 5 | 433771abefc5bcb89bdae64af45cce7407bffe5d | |
| ToppCell | PND28-Immune-Immune_Myeloid|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.37e-05 | 166 | 119 | 5 | caa992944bc7488a6868dbd1902bc3ead6945eb1 | |
| ToppCell | Influenza_Severe-Neutrophil|World / Disease group and Cell class | 9.11e-05 | 169 | 119 | 5 | 6e8e2580e19c96bcf7fa6a6d8c183df65f428396 | |
| ToppCell | normal_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 9.37e-05 | 170 | 119 | 5 | d69c0ea4cb6b204f19d0a5d2164afb42184779ac | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.37e-05 | 170 | 119 | 5 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | severe_influenza-Neutrophil|severe_influenza / disease group, cell group and cell class (v2) | 1.02e-04 | 173 | 119 | 5 | 615e266419b9f06e964eff73cb466f05451ba0dd | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 173 | 119 | 5 | 9ba55e21d1037ec3150d77895e52f0b051df65da | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-B_cells-Cycling_B_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-04 | 173 | 119 | 5 | b7e0193fd4983cb38d1bee441f608f73ee8743b9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 174 | 119 | 5 | 5f4436863a40f8bca46e2989bca66c02b6be88d4 | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 1.04e-04 | 174 | 119 | 5 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.04e-04 | 174 | 119 | 5 | 9aa2168d3bcef7cdc5a47442618cb8e9eb24c95b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 175 | 119 | 5 | 77c16e615c0fb9c83f29d7e0a547be72635fac81 | |
| ToppCell | facs-Skin-nan-18m-Epithelial-inner_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 176 | 119 | 5 | 086197acbfec4ac0c15b7e9721871aaa9e32e219 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-04 | 177 | 119 | 5 | f35b04c3557ebbdeba37dec54c8f45880eafb422 | |
| ToppCell | (3)_Chondrocytes-(32)_Chondro-prehyper-2|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.16e-04 | 178 | 119 | 5 | c569a406c3ae183a278d8540e8eba58f4f26c5b0 | |
| ToppCell | facs-BAT-Fat-3m-Lymphocytic-T_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 178 | 119 | 5 | 7c101e3957ea9b0d4ebf619d1d02e7e64ae28915 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.19e-04 | 179 | 119 | 5 | 4f20540bfbcefe0e83812be7ea542e8bb3bf19bc | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.19e-04 | 179 | 119 | 5 | f5bb4d3a27d56698473219970e764084096cc582 | |
| ToppCell | droplet-Limb_Muscle-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 179 | 119 | 5 | 013818e173101efca7625ccd4258e60655815d73 | |
| ToppCell | COVID-19-kidney-REN+Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 1.19e-04 | 179 | 119 | 5 | 342c1cc4444f51b8dcb30d3adc98285a25669c6e | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.19e-04 | 179 | 119 | 5 | fa03ec3cc0132f977b4cb28e7b23789732375183 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell-TA|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.22e-04 | 180 | 119 | 5 | 271ee52ed8f21f78ddf68e52fc88fe582701675e | |
| ToppCell | CV-Healthy-2|CV / Virus stimulation, Condition and Cluster | 1.22e-04 | 180 | 119 | 5 | e182e5c495dd82d4fcbf1a920086c70b064801f3 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 180 | 119 | 5 | f6a05b3751b01e74b2de8440801b0eb2e723c199 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 180 | 119 | 5 | dfc75ae4395ff46fbec2c54915d98ead5a1ba1a1 | |
| ToppCell | COVID-19_Convalescent|World / Disease condition and Cell class | 1.26e-04 | 181 | 119 | 5 | a62115a8da486fc61225901c72b1ec70bcaf4c36 | |
| ToppCell | LA-11._Adipocyte|LA / Chamber and Cluster_Paper | 1.32e-04 | 183 | 119 | 5 | 3f9011976782fa8aa95cdd6f00f07a91094d411b | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.32e-04 | 183 | 119 | 5 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-04 | 184 | 119 | 5 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 184 | 119 | 5 | 3da93e7d8b62463e307cc0425c47dbd3bef66799 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-04 | 184 | 119 | 5 | 282118f8221fa383ffb81dfb5798a0b7f065f911 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 1.36e-04 | 184 | 119 | 5 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 185 | 119 | 5 | 7092436b4db90289516ed130ade596e3021cffaf | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.39e-04 | 185 | 119 | 5 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 1.39e-04 | 185 | 119 | 5 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | droplet-Fat-Mat-18m-Lymphocytic-B_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 185 | 119 | 5 | 98bb853c495eb16c3663685a8e20755bd309b520 | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 185 | 119 | 5 | 8b381706b656d366b63adb9703db1c3dc796b3f8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 185 | 119 | 5 | a8ca7819066d5297ef6966e7f3e2c9f8a7673fdc | |
| ToppCell | COVID-19-Fibroblasts-Pericytes|COVID-19 / group, cell type (main and fine annotations) | 1.39e-04 | 185 | 119 | 5 | 4905adaeeffd353e089578e5ea614437dbe794e6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 185 | 119 | 5 | 9438097e94219c1db922b8507e3a29106d32a923 | |
| ToppCell | Influenza-Influenza_Severe-Myeloid-Neutrophil|Influenza_Severe / Disease, condition lineage and cell class | 1.43e-04 | 186 | 119 | 5 | 1dfcec9196d4db76fba3abc74e85885b1fb98b87 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-04 | 186 | 119 | 5 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | COPD-Stromal-Pericyte|World / Disease state, Lineage and Cell class | 1.43e-04 | 186 | 119 | 5 | 8adfd2d1fda4e8aecc95192ea627bf7ed5214b8d | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-04 | 186 | 119 | 5 | 722da08cd978249a19855fd3ec8ddda780c99d83 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.46e-04 | 187 | 119 | 5 | b8f88599e22b9b345c7ec3bbecd87a8b2a033f9f | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Lymphocytic-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 187 | 119 | 5 | 16b2fddf2c23a29f173102f117876c9df5544ae4 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 187 | 119 | 5 | 38ee33295a21db4aae5ba085df033db9693e41c6 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 187 | 119 | 5 | dbcec24d2c852964736c78e9d81650bff5c455ae | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 187 | 119 | 5 | e93cad16a087d1443cbf4e1690dc1b35d7a84c41 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.50e-04 | 188 | 119 | 5 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.50e-04 | 188 | 119 | 5 | c2321a3a1d9603f8b4b4fc09707eb32ec1e04f3f | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 1.54e-04 | 189 | 119 | 5 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | CF-Lymphoid-B_cell|CF / Disease state, Lineage and Cell class | 1.58e-04 | 190 | 119 | 5 | 374d8fd63c733178acab07682ed1519693efab45 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.58e-04 | 190 | 119 | 5 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-04 | 190 | 119 | 5 | b3bccf4dd95e986db3cee324a6737f5fcc22e8e5 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.58e-04 | 190 | 119 | 5 | 1519f34d31fe0817184c5865a0bc9f0cb479b1a4 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.58e-04 | 190 | 119 | 5 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.58e-04 | 190 | 119 | 5 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_B-ABC_aged-B_memory|lymph-node_spleen / Manually curated celltypes from each tissue | 1.62e-04 | 191 | 119 | 5 | c3ca8077da8594fb493e47ac4dfbbd20bfc14b37 | |
| ToppCell | 10x5'-Lung-Myeloid_Monocytic-Nonclassical_monocytes|Lung / Manually curated celltypes from each tissue | 1.62e-04 | 191 | 119 | 5 | a862a571625ab7238589ff201e5954f602c3bd7e | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 1.62e-04 | 191 | 119 | 5 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| Drug | ciglitazone | 3.04e-06 | 169 | 119 | 8 | CID000002750 | |
| Drug | 0198306-0000 [212631-61-3]; Down 200; 10uM; MCF7; HT_HG-U133A | 8.73e-06 | 195 | 119 | 8 | 7099_DN | |
| Drug | Zuclopenthixol hydrochloride [633-59-0]; Down 200; 9.2uM; HL60; HT_HG-U133A | 9.07e-06 | 196 | 119 | 8 | 2936_DN | |
| Drug | (+,-)-Octopamine hydrochloride [770-05-8]; Down 200; 21uM; HL60; HT_HG-U133A | 9.76e-06 | 198 | 119 | 8 | 3112_DN | |
| Drug | Merbromin [129-16-8]; Down 200; 5uM; HL60; HT_HG-U133A | 1.01e-05 | 199 | 119 | 8 | 2577_DN | |
| Disease | intellectual disability (implicated_via_orthology) | 4.97e-07 | 75 | 115 | 6 | DOID:1059 (implicated_via_orthology) | |
| Disease | Epilepsy, Cryptogenic | 1.77e-05 | 82 | 115 | 5 | C0086237 | |
| Disease | Awakening Epilepsy | 1.77e-05 | 82 | 115 | 5 | C0751111 | |
| Disease | Aura | 1.77e-05 | 82 | 115 | 5 | C0236018 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.00e-05 | 152 | 115 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Schizophrenia | GABRB2 SOX5 FMR1 GRIK1 IDE NR3C1 XRCC4 PTGS2 IGF2BP2 SLC26A7 AKT1 MAP2K7 IL4 | 4.15e-05 | 883 | 115 | 13 | C0036341 |
| Disease | Fibrosis | 4.39e-05 | 50 | 115 | 4 | C0016059 | |
| Disease | Cirrhosis | 4.39e-05 | 50 | 115 | 4 | C1623038 | |
| Disease | Epilepsy | 6.97e-05 | 109 | 115 | 5 | C0014544 | |
| Disease | spinocerebellar ataxia type 5 (implicated_via_orthology) | 8.99e-05 | 4 | 115 | 2 | DOID:0050882 (implicated_via_orthology) | |
| Disease | Xeroderma Pigmentosum | 8.99e-05 | 4 | 115 | 2 | C0043346 | |
| Disease | Cardiomyopathies | 1.60e-04 | 130 | 115 | 5 | C0878544 | |
| Disease | attention deficit hyperactivity disorder (implicated_via_orthology) | 1.76e-04 | 28 | 115 | 3 | DOID:1094 (implicated_via_orthology) | |
| Disease | prostate carcinoma in situ (is_marker_for) | 1.76e-04 | 28 | 115 | 3 | DOID:8634 (is_marker_for) | |
| Disease | xeroderma pigmentosum (is_implicated_in) | 2.24e-04 | 6 | 115 | 2 | DOID:0050427 (is_implicated_in) | |
| Disease | cortical thickness | SOX5 ANO2 CNBD1 SUPT3H RPL37A SPTBN1 MEF2C PXK FZD9 CADPS FBXO42 PRKAR2A SNTB1 | 4.06e-04 | 1113 | 115 | 13 | EFO_0004840 |
| Disease | heart disease (implicated_via_orthology) | 4.40e-04 | 38 | 115 | 3 | DOID:114 (implicated_via_orthology) | |
| Disease | Mood Disorders | 5.22e-04 | 168 | 115 | 5 | C0525045 | |
| Disease | phosphatidylinositol measurement | 5.30e-04 | 95 | 115 | 4 | EFO_0010230 | |
| Disease | Xeroderma pigmentosum | 5.32e-04 | 9 | 115 | 2 | cv:C0043346 | |
| Disease | lung cancer (implicated_via_orthology) | 5.32e-04 | 9 | 115 | 2 | DOID:1324 (implicated_via_orthology) | |
| Disease | Cutaneous Melanoma | 5.52e-04 | 41 | 115 | 3 | C0151779 | |
| Disease | Autistic Disorder | 5.69e-04 | 261 | 115 | 6 | C0004352 | |
| Disease | cholesteryl ester 22:5 measurement | 6.64e-04 | 10 | 115 | 2 | EFO_0021444 | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 7.73e-04 | 105 | 115 | 4 | DOID:9352 (implicated_via_orthology) | |
| Disease | Premature Birth | 8.09e-04 | 11 | 115 | 2 | C0151526 | |
| Disease | Basal cell carcinoma | 8.09e-04 | 11 | 115 | 2 | C0007117 | |
| Disease | Condition, Preneoplastic | 9.20e-04 | 110 | 115 | 4 | C0282313 | |
| Disease | Precancerous Conditions | 9.20e-04 | 110 | 115 | 4 | C0032927 | |
| Disease | glycerophospholipid measurement | 9.32e-04 | 49 | 115 | 3 | EFO_0007630 | |
| Disease | disks large homolog 3 measurement | 9.69e-04 | 12 | 115 | 2 | EFO_0802472 | |
| Disease | pancreatic cancer (is_implicated_in) | 9.84e-04 | 112 | 115 | 4 | DOID:1793 (is_implicated_in) | |
| Disease | velocity of sound measurement | 1.14e-03 | 13 | 115 | 2 | EFO_0005654 | |
| Disease | Charcot-Marie-Tooth disease type 4 | 1.14e-03 | 13 | 115 | 2 | cv:C4082197 | |
| Disease | Obesity | 1.27e-03 | 205 | 115 | 5 | C0028754 | |
| Disease | Squamous cell carcinoma | 1.43e-03 | 124 | 115 | 4 | C0007137 | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 1.45e-03 | 57 | 115 | 3 | DOID:10652 (implicated_via_orthology) | |
| Disease | Libman-Sacks Disease | 1.52e-03 | 58 | 115 | 3 | C0242380 | |
| Disease | forehead morphology measurement | 1.53e-03 | 15 | 115 | 2 | EFO_0007844 | |
| Disease | tumor necrosis factor beta measurement | 1.53e-03 | 15 | 115 | 2 | EFO_0008308 | |
| Disease | Malignant neoplasm of skin | 1.60e-03 | 59 | 115 | 3 | C0007114 | |
| Disease | Skin Neoplasms | 1.60e-03 | 59 | 115 | 3 | C0037286 | |
| Disease | hypertension (implicated_via_orthology) | 1.61e-03 | 128 | 115 | 4 | DOID:10763 (implicated_via_orthology) | |
| Disease | renal cell carcinoma (is_marker_for) | 1.61e-03 | 128 | 115 | 4 | DOID:4450 (is_marker_for) | |
| Disease | Chromosome Aberrations | 1.74e-03 | 16 | 115 | 2 | C0008625 | |
| Disease | Autosome Abnormalities | 1.74e-03 | 16 | 115 | 2 | C0004403 | |
| Disease | Polyposis, Adenomatous Intestinal | 1.74e-03 | 16 | 115 | 2 | C2713442 | |
| Disease | Familial Intestinal Polyposis | 1.74e-03 | 16 | 115 | 2 | C2713443 | |
| Disease | immunoglobulin lambda-like polypeptide 1 measurement | 1.74e-03 | 16 | 115 | 2 | EFO_0801688 | |
| Disease | Adenomatous Polyposis Coli | 1.97e-03 | 17 | 115 | 2 | C0032580 | |
| Disease | noggin measurement | 2.21e-03 | 18 | 115 | 2 | EFO_0021995 | |
| Disease | cortical surface area measurement | SOX5 ANO2 CNBD1 SUPT3H RPL37A SPTBN1 PICALM MEF2C FZD9 CADPS FBXO42 PRKAR2A SNTB1 | 2.26e-03 | 1345 | 115 | 13 | EFO_0010736 |
| Disease | facial asymmetry measurement | 2.47e-03 | 19 | 115 | 2 | EFO_0009751 | |
| Disease | Cardiomyopathies, Primary | 2.51e-03 | 69 | 115 | 3 | C0033141 | |
| Disease | Myocardial Diseases, Secondary | 2.51e-03 | 69 | 115 | 3 | C0036529 | |
| Disease | Lupus Erythematosus, Systemic | 2.72e-03 | 71 | 115 | 3 | C0024141 | |
| Disease | anti-Mullerian hormone measurement | 2.73e-03 | 20 | 115 | 2 | EFO_0004769 | |
| Disease | unipolar depression, bipolar disorder, schizophrenia | 2.73e-03 | 20 | 115 | 2 | EFO_0003761, MONDO_0004985, MONDO_0005090 | |
| Disease | melanoma | 2.92e-03 | 248 | 115 | 5 | C0025202 | |
| Disease | in situ carcinoma (is_marker_for) | 3.01e-03 | 21 | 115 | 2 | DOID:8719 (is_marker_for) | |
| Disease | status epilepticus (implicated_via_orthology) | 3.01e-03 | 21 | 115 | 2 | DOID:1824 (implicated_via_orthology) | |
| Disease | depressive disorder (implicated_via_orthology) | 3.31e-03 | 22 | 115 | 2 | DOID:1596 (implicated_via_orthology) | |
| Disease | free androgen index | 3.52e-03 | 374 | 115 | 6 | EFO_0007005 | |
| Disease | idiopathic pulmonary fibrosis (is_marker_for) | 3.61e-03 | 23 | 115 | 2 | DOID:0050156 (is_marker_for) | |
| Disease | epilepsy (implicated_via_orthology) | 3.86e-03 | 163 | 115 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | Lung Neoplasms | 3.87e-03 | 265 | 115 | 5 | C0024121 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LVKEKATGRYYAMKI | 166 | P31749 | |
| ATGRYYAMKILKKEV | 171 | P31749 | |
| KEKEEMRKIIGRYGL | 491 | Q9UG63 | |
| LKEMKKGKEFYVIFD | 216 | P39086 | |
| KIPKEFIMKYKRGEI | 81 | Q96M93 | |
| VDVGKKKADISYMRF | 446 | Q9BWV3 | |
| EFLKIKVPTKKEMYE | 201 | Q9NQ90 | |
| GKMQREKYLTILKAV | 2156 | Q8IZT6 | |
| VDVKVVMLGKEYVGK | 6 | Q969Q5 | |
| RKEMSLAKLGYFKEE | 461 | Q96QF0 | |
| TFKTLERMKKYVFID | 856 | Q6IE37 | |
| LKTLIRMVKKTYRDF | 1286 | Q9ULU8 | |
| MYVLDIKDTKEKGRV | 646 | Q6P3S6 | |
| RDKVLFYGRKIMRKV | 101 | Q8IY17 | |
| VRLKKTDRIYAMKVV | 271 | P41743 | |
| TDRIYAMKVVKKELV | 276 | P41743 | |
| LKIYDRMKAKEFTGI | 1686 | Q9NU22 | |
| KYRVKGLITKAEMLG | 236 | P43364 | |
| EKMKKTGRNIIVFYG | 71 | P16435 | |
| YIKKLMTKGRYSLDV | 661 | P16435 | |
| ELKVKTVKYFKGLML | 246 | P46926 | |
| EVVEIFKKQLMKFRY | 991 | Q86WG5 | |
| KKLKFYLRDMTLSEG | 26 | Q86W26 | |
| EKKKVMGVLDIYGFE | 371 | Q9UBC5 | |
| DKKVEMLERKYGGSF | 331 | Q5JU85 | |
| KMTVAIVKALYYLKE | 221 | O14733 | |
| KVAIKKIMKRIFYSE | 296 | Q8NHC7 | |
| VFLKQIEKTMKRAYE | 416 | A0PJZ3 | |
| MKKAIPKVRLETIYI | 116 | Q53F19 | |
| RLFKDGKMKYQIIDG | 231 | P35354 | |
| KEFGILAKTKYFQML | 2136 | P50748 | |
| FTKRKFGLMKKAYEL | 21 | Q06413 | |
| EKMRLDVNKIFYKDI | 351 | P47870 | |
| MTYIKELGKAIVKRE | 691 | P04150 | |
| FGKMETYIKLEKLGE | 186 | Q00537 | |
| GKIMEVDYSVSKKLR | 66 | Q9Y6M1 | |
| FTKRKFGLMKKAYEL | 21 | Q02078 | |
| TRYGASLRKMVKKIE | 16 | P61513 | |
| FTKRKFGLMKKAYEL | 21 | Q02080 | |
| DMFILGYSLEVKIKV | 301 | Q9NUU6 | |
| FRKGIMKIMVYKIFR | 136 | Q9BUE0 | |
| ISYVFEGKMLEAKKL | 571 | O95248 | |
| LEKLMVKIGVFSILY | 441 | O00144 | |
| LAKVRMIKGEFYVIE | 81 | Q06787 | |
| FLERLKTIMREKYSK | 136 | P05112 | |
| TYGTIVKMKRDDLKA | 101 | A1XBS5 | |
| GIRKLYMKSLLKIFA | 41 | Q86UL3 | |
| DLYKFLTKRGEKMTR | 126 | A8K855 | |
| GTMEKYLKEVLRIKF | 251 | P35790 | |
| KAKLTEMRGIYAKVD | 101 | Q8TDM0 | |
| SGELVAIKRMKRKFY | 26 | P20794 | |
| ELRVKTVKYFKGLMH | 246 | Q8TDQ7 | |
| KMLLKEYEERVIIKG | 631 | Q8N7U6 | |
| MKIVDVIGEKIYKDG | 271 | P13861 | |
| LTKEDIIKFYKEMLA | 931 | P14735 | |
| LLMLVYKDKSERIKG | 36 | Q18PE1 | |
| LGIIKAKMEEYFQKV | 711 | A6NE01 | |
| AFLVTLLIYRMKKKD | 401 | O75056 | |
| LLIYRMKKKDEGSYT | 406 | O75056 | |
| KVMLKEYSGRKIEVE | 186 | O00237 | |
| KMLDYLKEKKDVGFF | 3776 | Q92736 | |
| DRLSILLKGKMKVSY | 171 | Q8NE79 | |
| MLDKIMIIFRFIYGK | 586 | Q13620 | |
| MVKLQEIFKTFYLGK | 701 | Q13620 | |
| AGLEVTVDFKKLMKY | 861 | Q8NG08 | |
| FTKRKFGLMKKAYEL | 21 | Q14814 | |
| KLFGYEMAEFKVTIK | 191 | Q9UKD2 | |
| MVNEYKKILLLKGFE | 1 | P41218 | |
| KMKLDYILGLKIEDF | 91 | P46781 | |
| LITYLGAKMTRKYKE | 1871 | Q5TCS8 | |
| KRAGKEVLLEVKYMR | 181 | Q13884 | |
| FYIVEQRMKTKGEKV | 391 | P49590 | |
| AFYIIMKLRSGERIK | 731 | Q8NBJ9 | |
| SGLDKKAKYILLMDI | 141 | O15119 | |
| KEIKIYLGLSKMQRE | 411 | P28370 | |
| LTGYKMKKRVGAIEE | 251 | Q5TGY1 | |
| GYQAKLFKGVLKERM | 301 | Q6XZB0 | |
| MKAYRDTIKILQLGK | 341 | Q6PI26 | |
| LFKIDKEYLLKMATE | 156 | P21673 | |
| VKEALIKELSMKIYF | 296 | Q8NGP6 | |
| IGKMRYVSVRDFKGK | 66 | P53999 | |
| LGKYKDLLMKAETER | 51 | Q9H0H5 | |
| LEFYKKDGLRKIQSM | 501 | Q17R89 | |
| QLGTTIYKEFEKRKM | 331 | P53597 | |
| FSKRKTGIMKKAYEL | 161 | P11831 | |
| YFSKMKALAVEGKRI | 276 | Q01082 | |
| SLEIYKKMFEVKRRE | 31 | Q9H6E4 | |
| NLKKFRYVKLISMET | 16 | Q9BWT1 | |
| VYMGKLKEKESFGEI | 391 | Q8NA66 | |
| VVLKEYLTMKAFVAK | 201 | P35523 | |
| ETMEVKTLGKLERYK | 551 | Q9Y2G3 | |
| KEGLDIYKKFLTRMT | 231 | Q13492 | |
| IYELLFKEGVMVAKK | 11 | P46783 | |
| KLFYKAIVRGKEMIR | 2806 | O15417 | |
| EIIKVYLKGRSGDKM | 76 | Q9NNX1 | |
| VYLDLTLDMALGKKK | 121 | Q9BYD6 | |
| GKIYFLLVRIKIKHM | 191 | Q4G0F5 | |
| EKDLMKAYLFKGNIL | 96 | Q9P2K2 | |
| MKDLIKVAIKIGILY | 166 | Q5GJ75 | |
| KVMYKGLVPEDKTLR | 126 | O14562 | |
| VVYRKLMGKKGTFRD | 636 | Q05086 | |
| MFIRDYKSKIVKGID | 101 | O75486 | |
| YGHIIKVFLMKDRKT | 31 | Q8N7X1 | |
| RVSGLDKKAKYILLM | 141 | Q13207 | |
| ALVLYIVFIFAMKKK | 636 | Q9NPD5 | |
| MEKGKYVGELRKALL | 61 | Q13426 | |
| EGYFTAIMLKKSRVK | 176 | O95551 | |
| KLVETMYFKGIEAGK | 356 | Q86UB9 | |
| RMFNEKGTLKDLIYK | 226 | Q7Z7A4 | |
| LRYEIKQIKMFKGFE | 71 | Q99727 | |
| YFSKMKVLAVEGKRV | 276 | P11277 | |
| RLDFELGKMIKQSYK | 506 | Q9NZM6 | |
| EMVGIIYKPKTKETR | 96 | O75643 | |
| GDMKLYLKLQIVKRS | 176 | P23025 | |
| RLFSKVLVTIKKVYM | 136 | B4DU55 | |
| VLVTIKKVYMKERSF | 141 | B4DU55 | |
| KKVYMKERSFKGVEF | 146 | B4DU55 | |
| ILRKMGKSVDYFLSI | 241 | Q2M3R5 | |
| DGKKLRIGEYKAIMR | 636 | P35711 | |
| KIKLEFETYLRRAMK | 181 | Q01831 | |
| KIMRFVDKITKSKYF | 986 | Q8IWB9 | |
| GLKGMLIQFRDLKKY | 416 | Q8TE54 | |
| MVGSKLKVIFLENYR | 636 | P06737 | |
| KQRKLNFLEIYGEKM | 391 | Q9P1Q0 | |
| TKVRKKVMGVLDIYG | 376 | O43795 | |
| AELSVYGKLRKVAKM | 596 | Q6IA69 | |
| IEELSKKDKGIYRAM | 1176 | Q5VTT5 | |
| SKMLSGREYKKLFEE | 296 | O76041 |